Galapagos | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
AstraZeneca USD 5.23B 258M 2025-03
Biogen USD 2.6B 223.3M 2025-03
Genmab DKK 1.62B 8.24B 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
GRIFOLS EUR 752.82M 226.96M 2025-03
Hikma Pharmaceutical USD 0 1000K 2024-06
Incyte USD 2.41B 720.83M 2025-03
Merck EUR 2.15B 1.01B 2024-12
Neurocrine Biosciences USD 233M 116.1M 2024-12
Novartis USD 8.87B 4.74B 2024-12
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
UCB EUR 1.57B 1.14B 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Galapagos Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.